Skip to main content

Understanding the Types of Weight-Loss Medications

What it is: Medications that regulate appetite and slow digestion to help you feel full longer.

How it works: These drugs mimic a hormone called GLP-1 that regulates appetite and blood sugar levels. They slow stomach emptying, reduce hunger and increase feelings of fullness, helping individuals eat less.

Who it’s not for: Individuals with a history of pancreatitis, medullary thyroid cancer or specific allergies should avoid GLP-1 agonists. Pregnant or breastfeeding individuals should also not use these medications.

Expected results: Average weight loss of 10-20 percent of your total body weight over 12-16 months.

*Tirzepatide is a GLP-1 and GIP receptor agonist

What it is: Medications that reduce hunger and cravings, helping you eat less.

How it works: These medications affect the central nervous system to decrease appetite, helping to limit calorie intake.

Who it’s not for: People with uncontrolled hypertension, heart disease, glaucoma or a history of substance misuse should avoid these medications.

Expected results: 5-12 percent of total body weight loss in as little as 3-12 months.

What it is: Targets appetite and cravings, especially for emotional eating.

How it works: This medication combines bupropion, an antidepressant, with naltrexone, typically used to treat addiction, to target appetite and cravings. The combination acts on brain pathways to reduce hunger and food cravings, especially for emotional eating.

Who is it for: Patients who struggle with food cravings or emotional eating patterns, and who may benefit from the mood-stabilizing effects of bupropion.

Who it’s not for: People with a history of seizures, eating disorders, or those taking opioid pain medications should avoid this treatment.

Expected results: 5-6 percent of total body weight loss over 12 months.

What it is: Blocks dietary fat absorption, reducing calorie intake.

How it works: By inhibiting the enzyme lipase, it prevents about 30 percent of dietary fat from being absorbed, instead eliminating it through bowel movements.

Who is it for: Those who consume a diet with moderate to high fat content and are seeking a non-stimulant medication option.

Who it’s not for: Individuals with chronic malabsorption syndromes or gallbladder issues may not tolerate this medication well.

Expected results: 5-8 percent weight loss over 6-12 months.

Back to Top